oligopeptide-48은 임신 중 안전한가요?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety opinion identified for oligopeptide-48. No peer‑reviewed reports of developmental or reproductive toxicity associated with this ingredient were found in available regulatory/academic sources. Peptides used topically are generally of low dermal absorption; absent specific data, default to no evidence of reproductive hazard. Sources consulted: ECHA Annex VI, SCCS/CIR databases, PubMed, CosIng, PubChem.
성분
oligopeptide-48
알려진 위험 없음100
/100
0
Related ingredients
Frequently asked questions
- oligopeptide-48은 임신 중 안전한가요?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR reproductive safety opinion identified for oligopeptide-48. No peer‑reviewed reports of developmental or reproductive toxicity associated with this ingredient were found in available regulatory/academic sources. Peptides used topically are generally of low dermal absorption; absent specific data, default to no evidence of reproductive hazard. Sources consulted: ECHA Annex VI, SCCS/CIR databases, PubMed, CosIng, PubChem.
- oligopeptide-48은 모유 수유 중 안전한가요?
- No evidence from harmonised classifications, CIR or SCCS opinions, or published studies that oligopeptide-48 poses reproductive or lactation transfer risks. No data demonstrating placental transfer or mammary secretion. Topical peptide use typically shows negligible systemic exposure, so breastfeeding exposure is judged negligible in absence of data. Sources: ECHA Annex VI, CIR, SCCS, PubMed, PubChem, CosIng.
- oligopeptide-48은 아기 피부에 안전한가요?
- No infant-specific toxicology or adverse effects reported for oligopeptide-48. Mechanistic data lacking. While adult dermal absorption is judged negligible for peptides, immature infant skin has higher permeability; per scoring rules, exposure for 0–3 yr is increased by +1 (adult e=0 → baby e=1) in the absence of definitive non‑absorbability data. Sources: general peptide dermal absorption knowledge, CosIng, PubChem, PubMed (no infant data).
- VeriMom은 oligopeptide-48을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 oligopeptide-48을 100/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 oligopeptide-48 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.